Keywords: Cancer, Head & Neck/ENT, Oral Squamous Cell Carcinoma, 1H NMR, Biomarker
Motivation: Early detection of oral cancer remains challenging. There’s a critical need for accessible, non-invasive biomarkers that can improve early diagnosis, helping to enhance survival rates and treatment outcomes for Oral Squamous Cell Carcinoma (OSCC) patients.
Goal(s): To identify potential diagnostic biomarkers for OSCC by profiling metabolic changes in serum and saliva.
Approach: Using 1H NMR metabolomics, saliva and serum were analyzed to identify pathway and metabolic alteration in OSCC patients compared to controls.
Results: Elevated methanol and disrupted phenylalanine, tyrosine, and tryptophan pathways were observed in both biofluids, indicating potential OSCC biomarkers. The combined biofluid approach shows promise for non-invasive early OSCC detection.
Impact: This study highlights the potential of using combined serum and saliva metabolomic profiling as a non-invasive approach to identify reliable biomarkers for early OSCC detection, offering a promising tool for improved diagnostic accuracy and timely intervention.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords